Sagimet Biosciences (SGMT) Beats Q4 Earnings Estimates by $0.12
Sagimet Biosciences (NASDAQ:SGMT) reported quarterly earnings results on March 11, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share of…
Read more
